The Mid-Atlantic Permanente Research Institute (MAPRI) is the research department of the Mid-Atlantic Permanente Medical Group, PC, (MAPMG) and Kaiser Permanente Mid-Atlantic (KPMAS), serving approximately 500,000 members at 31 Kaiser Permanente Medical Centers in the District of Columbia (DC), Maryland, and Northern Virginia. MAPRI is located on the third floor of Kaiser Permanente’s Regional Offices in Rockville, Maryland, within the Mid-Atlantic Permanente Medical Group. MAPRI’s mission is to address the clinical, health policy, and service questions perplexing MAPMG providers, the medical program, and the healthcare system, aiming to improve the care experience of our patients and communities we serve.
MAPRI has seven research scientists and over 15 affiliated clinician researchers, in various clinical fields and disciplines. Additional department resources include grant administration support, data managers and analysts, clinical research nurses and assistants, and biostatisticians. MAPRI offers expertise in health services research, including health disparities and economic impact of healthcare, epidemiology, health information technology, disease specific research in infectious diseases (including HIV/AIDS and hepatitis) and oncology, and clinical trials, all within a racially and ethnically diverse population. Currently, MAPRI is developing the following registries:
- Parkinson’s disease
- Sickle Cell
- Heart Failure
- Rheumatoid Arthritis
In addition, collaborative ties exist with various local institutions, including Johns Hopkins and Georgetown Universities, as well as other organizations across the U.S., including other Kaiser Permanente research units and the Health Care Systems Research Network (HCSRN), Cancer Research Network (CRN), and the FDA Mini-Sentinel Initiative.